Research output per year
Research output per year
Fingerprint
Dive into the research topics where Drew Pardoll is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
Hahn, N. M., O'Donnell, M. A., Efstathiou, J. A., Zahurak, M., Rosner, G. L., Smith, J., Kates, M. R., Bivalacqua, T. J., Tran, P. T., Song, D. Y., Baras, A. S., Matoso, A., Choi, W., Smith, K. N., Pardoll, D. M., Marchionni, L., McGuire, B., Grace Phelan, M., Johnson, B. A., O'Neal, T., & 21 others, Jun 2023, In: European Urology. 83, 6, p. 486-494 9 p.Research output: Contribution to journal › Article › peer-review
-
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer
Rosner, S., Reuss, J. E., Zahurak, M., Zhang, J., Zeng, Z., Taube, J., Anagnostou, V., Smith, K. N., Riemer, J., Illei, P. B., Broderick, S. R., Jones, D. R., Topalian, S. L., Pardoll, D. M., Brahmer, J. R., Chaft, J. E. & Forde, P. M., Feb 16 2023, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 29, 4, p. 705-710 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Helminth egg derivatives as proregenerative immunotherapies
Maestas, D. R., Chung, L., Han, J., Wang, X., Sommerfeld, S. D., Kelly, S. H., Moore, E., Nguyen, H. H., Mejías, J. C., Peña, A. N., Zhang, H., Hooks, J. S. T., Chin, A. F., Andorko, J. I., Berlinicke, C. A., Krishnan, K., Choi, Y., Anderson, A. E., Mahatme, R., Mejia, C., & 9 others, Feb 21 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 8, e2211703120.Research output: Contribution to journal › Article › peer-review
Open Access -
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial
Shenderov, E., De Marzo, A. M., Lotan, T. L., Wang, H., Chan, S., Lim, S. J., Ji, H., Allaf, M. E., Chapman, C., Moore, P. A., Chen, F., Sorg, K., White, A. M., Church, S. E., Hudson, B., Fields, P. A., Hu, S., Denmeade, S. R., Pienta, K. J., Pavlovich, C. P., & 4 others, Apr 2023, In: Nature medicine. 29, 4, p. 888-897 10 p.Research output: Contribution to journal › Article › peer-review
-
Persistent mutation burden drives sustained anti-tumor immune responses
Niknafs, N., Balan, A., Cherry, C., Hummelink, K., Monkhorst, K., Shao, X. M., Belcaid, Z., Marrone, K. A., Murray, J., Smith, K. N., Levy, B., Feliciano, J., Hann, C. L., Lam, V., Pardoll, D. M., Karchin, R., Seiwert, T. Y., Brahmer, J. R., Forde, P. M., Velculescu, V. E., & 1 others, Feb 2023, In: Nature medicine. 29, 2, p. 440-449 10 p.Research output: Contribution to journal › Article › peer-review
Open Access